China Health Group Statistics

Total Valuation

HKG:8225 has a market cap or net worth of HKD 163.24 million. The enterprise value is 145.65 million.

Market Cap	163.24M
Enterprise Value	145.65M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:8225 has 995.35 million shares outstanding.

Current Share Class	995.35M
Shares Outstanding	995.35M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	46.73%
Owned by Institutions (%)	n/a
Float	288.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.80
PB Ratio	2.20
P/TBV Ratio	2.18
P/FCF Ratio	18.00
P/OCF Ratio	14.92
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.43
EV / Sales	5.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	16.06

Financial Position

The company has a current ratio of 2.97

Current Ratio	2.97
Quick Ratio	2.35
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -18.87% and return on invested capital (ROIC) is -11.78%.

Return on Equity (ROE)	-18.87%
Return on Assets (ROA)	-8.23%
Return on Invested Capital (ROIC)	-11.78%
Return on Capital Employed (ROCE)	-20.81%
Revenue Per Employee	670,277
Profits Per Employee	-367,874
Employee Count	42
Asset Turnover	0.24
Inventory Turnover	n/a

Taxes

In the past 12 months, HKG:8225 has paid 48,952 in taxes.

Income Tax	48,952
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +69.79% in the last 52 weeks. The beta is 0.19, so HKG:8225's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	+69.79%
50-Day Moving Average	0.16
200-Day Moving Average	0.17
Relative Strength Index (RSI)	43.55
Average Volume (20 Days)	193,500

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:8225 had revenue of HKD 28.15 million and -15.45 million in losses. Loss per share was -0.02.

Revenue	28.15M
Gross Profit	10.71M
Operating Income	-15.44M
Pretax Income	-15.40M
Net Income	-15.45M
EBITDA	-14.79M
EBIT	-15.44M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 16.91 million in cash and n/a in debt, giving a net cash position of 16.91 million or 0.02 per share.

Cash & Cash Equivalents	16.91M
Total Debt	n/a
Net Cash	16.91M
Net Cash Per Share	0.02
Equity (Book Value)	74.19M
Book Value Per Share	0.08
Working Capital	65.33M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.94 million and capital expenditures -1.87 million, giving a free cash flow of 9.07 million.

Operating Cash Flow	10.94M
Capital Expenditures	-1.87M
Free Cash Flow	9.07M
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 38.05%, with operating and profit margins of -54.84% and -54.88%.

Gross Margin	38.05%
Operating Margin	-54.84%
Pretax Margin	-54.71%
Profit Margin	-54.88%
EBITDA Margin	-52.55%
EBIT Margin	-54.84%
FCF Margin	32.22%

Dividends & Yields

HKG:8225 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-9.47%
FCF Yield	5.56%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:8225 has an Altman Z-Score of 2.33 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.33
Piotroski F-Score	3